2022 Speakers Nida Sen Retina Global Clinical Development Janssen Lauren Ayton Associate Professor, & Head - Vision Optimisation University of Melbourne Lee Morris Patient Luxturna Patient (UK) Maen Obeidat Executive Director - Therapeutics Area Head, Biomarker Development, Ophthalmology Novartis Markus Peters Chief Executive Officer Aevitas Therapeutics (formerly) Matthew Wood Luxturna Patient (UK) Rachel Eclov Gene Therapy Development Project Leader Kriya Therapeutics Samarendra Mohanty Chief Scientific Officer & President Nanoscope Therapeutics Sanghoon Kim Project Engineer Nanoscope Therapeutics Subrata Batabyal Senior Technical Officer Nanoscope Technologies Viral Kansara Vice President of Preclinical Development Clearside Biomedical Yoreh Barak Director of Retina, Department of Ophthalmology Everads Therapy Diane Doughty Director of Device Development REGENXBIO Catherine Cukras Director of the Medical Retina Fellowship Program National Eye Institute (NEI) Ramkumar Ramamirtham Associate Director & Optometrist Novartis (NIBR) Shane Hegarty Chief Scientific Officer & Co Founder AXONIS Therapeutics Amy Mawdesley Product Manager Newcells Biotech Brianna Barrett Associate Director Technical Sales Forge Biologics Simon Kaja Chief Scientific Officer & Vice President Experimentica Cathleen Gonzales Director of Pharmacology Intergalactic Therapeutics Eric Buckland Founder & Chief Executive Officer Translational Imaging Innovations (TII) Miquel Vila-Perello Chief Executive Officer & Chief Scientific Officer SpliceBio Abraham Scaria Chief Scientific Offier AGTC Aniz Girach Chief Medical Officer ProQR Arun Upadhyay Senior Vice Preisent of Research & Development Ocugen Ashwath Jayagopal Chief Scientific Officer Opus Genetics Catherine O’Riordan Head Translational Cluster, Genomics Unit Sanofi Catarina Santos Europe Medical Director of Ophthalmology Novartis Rosario Fernandez-Godi Director, Head of Retina Biology Lab Intergalactic Therapeutics Claire Gelfman Chief Scientific Officer Foundation Fighting Blindness Daniel Chung Chief Medical Officer SparingVision Erin O’Neil Attending Physician Children’s Hospital of Philadelphia Francis Tukov Director, Preclinical Safety Assessment Novartis Gayathri Ramaswamy Vice President, Drug Discovery & Disease Biology Intergalactic Therapeutics Gerard Caelles Chief Business Officer SpliceBio Hemant Khanna Vice President of Preclinical Ocular Research IVERIC Bio Jake Ternent Patient Luxturna Jasmina Kapetanovic Clinician & Consultant Vitreo-Retinal Surgeon University of Oxford Shannon Boye Founder & Director Atsena Therapeutics Magali Taiel Chief Medical Officer GenSight Biologics Richard Beckman Chief Medical Officer Adverum Stephen Poor Director of External Opportunities & Translational Biomarkers Novartis Steve Pakola Chief Medical Officer REGENXBIO Stylianos Michalakis Co-founder & Chief Scientific Advisor ViGeneron Theresa Heah President & Chief Medical Officer Kriya Ophthalmology William Beltran Director, Division of Experimental Retinal Therapies University of Pennsylvania BACK TO TOP 2022 FULL EVENT GUIDE